A trial of ATRA and chemotherapy for pancreatic cancer (STARPAC-2 or PRIMUS-005)

Overview

Cancer types:

Pancreatic cancer

Status:

Open

Phase:

Phase 2

Details

This trial is looking at having ATRA with gemcitabine and nab-paclitaxel chemotherapy for pancreatic cancer.

It is for people whose cancer has grown just outside the pancreas and it isn’t possible to have surgery to remove it.

The STARPAC-2 trial is also called Primus-005.

The trial is part of a large research programme looking at new treatments for cancer of the pancreas. It is called Precision-Panc.

To take part in this trial most people will have already joined a study called Precision Panc. In this study, the researchers were looking at the make up of your cancer. The information they found out means that they can match you to treatment in this trial.